Ferenci, P; Laferl, H; Scherzer, TM; Maieron, A; Gschwantler, M; Brunner, H; Hubmann, R; Bischof, M; Staufer, K; Datz, C; Steindl-Munda, P; Kessler, H.
Customizing treatment with peginterferon alfa-2a (40kd) (PEGASYS (R)) plus ribavirin (COPEGUS (R)) in patients with HCV genotype 1 or 4 infection. Interim results of a prospective randomized trial
HEPATOLOGY. 2006; 44(4):336A-336A.
[Poster]
Web of Science